Visentin A, Mauro FR, Scarfo L, Gentile M, et al. Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study. Am J Hematol 2023 Jun 29. doi: 10.1002/ajh.27009.
PMID: 37382471